Friday 27th February 2026

13:30  Welcome and introduction (S. Aebi, Luzern)

13:35  Contrast enhanced mammography (CEM) and biopsy directed by CEM (C. Kurtz, Luzern)

14:05  Surgical management of the axilla (S. Bucher, Luzern)

14:35  Current standard of de-escalation in adjuvant radiation therapy (G. Gruber, Zürich)

15:05  Case presentation

15:20  Discussion   

15:40  Coffee break

16:10  Pathological approach of non-NST and non-epithelial tumors of the breast (Z. Varga, Zürich)

16:40  What design flaws should we look for in clinical trial reports? (T. Olivier, Genève)

17:10  Investigating de-escalation of oncological therapies: a primer on non-inferiority designs (D. Menges, Zürich)

17:40  Case presentations

18:10   Adjourn

Saturday 28th February 2026

08:00  An interactive guide to controversial issues of the St. Gallen Consensus 2025 (B. Thürlimann, Zürich)

08:40  Recent advances in endocrine therapy (E. Munzone, Milano)

09:20  Operable and advanced triple negative breast cancer: systemic therapy (R. Bartsch, Wien)

10:00  Coffee break

10:20  Optimum use of PARP-inhibitors (L. Rossi, Bellinzona)

11:10  Recent advances in HER2-directed therapy (A. Wolfer, Genève)

11:40  Discussion

11:55  Wrap up (S. Aebi, Luzern)

12:00   End